Bookmark

Add to MyYahoo RSS

Pharmaceutical News

Pharmaceuticals news continually updated from thousands of sources around the net.

41 min ago | The Motley Fool

Why Teva Pharmaceutical Industries Ltd Stock Is Great For a Dividend Portfolio

I say haystack because a lot of companies have paid a dividend, be it a regular dividend or special one, over the trailing 12 months -- and not all of those dividends are exactly high quality.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Healthcare Industry

4 hrs ago | WKXW-FM Trenton

Christie: University merger aiding pharmaceutical industry

He said while New Jersey remains a central location for pharmaceutical companies, some have departed because of the state's high taxes.

Comment?

Related Topix: Rutgers University

9 hrs ago | Investor's Business Daily

Lannett to Acquire Two Generic Pharmaceutical Products

Lannett Company, Inc. today announced that it has agreed to purchase ANDAs for Estradiol Tablets, USP, 0.5 mg, 1 mg and 2 mg, and Selegiline Hydrochloride Capsules 5 mg, upon the completion of a successful technical transfer.

Comment?

Related Topix: Lannett Company, Biotech, Medicine, Healthcare Industry

Wed Aug 20, 2014

Sys-Con Media

New Drug Launches, Technical Updates, New Facility, Clinical Trials...

Today, Analysts Review released its research reports regarding Covidien PLC , Mylan, Inc. , Baxter International Inc. , Achillion Pharmaceuticals, Inc. and Perrigo Company PLC .

Comment?

Related Topix: Biotech, Medicine, Mylan Laboratories, Healthcare Industry, Dey, Startups, Manufacturing, Industrial Machines, Foley, Covidien, VNUS Medical Technologies

TheStreet.com

Why Mylan (MYL) Stock Is Advancing Today

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Medicine, Mylan Laboratories, Healthcare Industry, Mozilla, Financial Markets

BioSpace

Achillion Pharmaceuticals, Inc. Granted U.S. Patent For ACH-3102 And...

Achillion Pharmaceuticals, Inc. today announced that the U.S. Patent & Trademark Office has granted Achillion U.S. Patent No.

Comment?

Related Topix: Achillion Pharmaceuticals, Patent / Trademark Law, Law, Hepatitis, Medicine, Health, Epidemic, Natural Disasters, Infectious Diseases

Investor's Business Daily

Bristol-Myers Squibb and Celgene Enter Clinical Collaboration...

Phase I study to evaluate OPDIVO , Bristol-Myers Squibb's investigational PD-1 immune checkpoint inhibitor, with Celgene's ABRAXANE A for multiple cancers NEW YORK & SUMMIT, N.J.-- -- Bristol-Myers Squibb Company and Celgene Corporation announced today the establishment of a clinical trial collaboration to evaluate the safety, tolerability and ... (more)

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Bristol-Myers Squibb, Celgene

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

John B. Sanfilippo & Son, Inc. Fourth Quarter EPS Increased by 15.7% to a Fourth Quarter Record $0.59 per Share Diluted )--John B. Sanfilippo & Son, Inc. today announced record operating results for both its fiscal 2014 fourth quarter and fisc... )--McKesson Corporation today announced that James Beer, the company's executive vice president and ... (more)

Comment?

Related Topix: Food, John B Sanfilippo and Son, Biotech, Medicine, McKesson, Household Products, Healthcare Industry, Trumbull, CT

Tue Aug 19, 2014

AmericanBankingNews.com

Achillion Pharmaceuticals major shareholder Sells $40,359,550 in Stock

Achillion Pharmaceuticals major shareholder Ra Capital Management, Llc sold 4,235,000 shares of the company's stock in a transaction that occurred on Monday, August 18th.

Comment?

Related Topix: Achillion Pharmaceuticals

The Motley Fool

3 Reasons Mylan Inc Stock Could Rise

Market highs have been a frequent occurrence so far in 2014, and the healthcare sector has been no stranger to the stock surge.

Comment?

Related Topix: Biotech, Medicine, Mylan Laboratories, Healthcare Industry, Teva Pharmaceutical Industries

Business Wire

Cannabics Pharmaceuticals recruits two former senior Teva Executives to its Advisory Board

Both Mr. Abravanel and Dr. Ariely-Portnoy have substantial expertise, experience and knowledge relevant to the Company's mission and anticipated needs.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry, Marijuana

Freshnews

Mylan Launches Generic Precedex(TM) Injection - Another Key Product Approval

Mylan Inc. announced that its business Mylan Institutional has launched Dexmedetomidine Hydrochloride Injection, 100 mcg /mL, packaged in 200 mcg /2 mL Single-dose Vials, which is therapeutically equivalent to Hospira's Precedex .

Comment?

Related Topix: Biotech, Medicine, Mylan Laboratories, Healthcare Industry, Dey, Startups, Food and Drug Administration

Forbes.com

Growth Stocks Are Back In Favor

Bob Turner: At Turner, we're encouraged by what we see in the market in general.

Comment?

Related Topix: Financial Markets, WebMD, Emerging Technology, Search Engines, Biotech, Medicine, McKesson, Household Products, Healthcare Industry, Financial Services

JD Supra

Court Report - August 2014 #3

Unimed Pharmaceuticals LLC et al. v. Perrigo Co. et al. 1:14-cv-01004; filed July 31, 2014 in the District Court of Delaware Unimed Pharmaceuticals LLC et al. v.

Comment?

Related Topix: 9, Medicine, Biotech, Impax Laboratories, Healthcare Industry, Zomig, Zolmitriptan (generic)

PR-inside.com

Report Published: "Itero Biopharmaceuticals, Inc. - Pharmaceuticals & ...

The company develops, manufactures and commercializes protein therapeutics. It develops and commercializes recombinant DNA-produced medicines which include monoclonal antibodies.

Comment?

Related Topix: Biotech, Watson Pharmaceuticals, Medicine, Healthcare Industry, Santa Clara County, CA, Mountain View, CA

Mon Aug 18, 2014

GlobeNewswire

Shareholder Alert: Brower Piven Encourages Investors Who Have Losses...

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Impax Laboratories Inc. securities during the period between May 20, 2013 and July 28, 2014, inclusive .

Comment?

Related Topix: Biotech, Impax Laboratories, Medicine, Healthcare Industry, Startups

AmericanBankingNews.com

Stock Traders Purchase High Volume of Teva Pharmaceutical Industries Ltd Call Options

Teva Pharmaceutical Industries Ltd saw some unusual options trading on Monday. Investors bought 54,686 call options on the stock, Analyst Ratings.Net reports.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry

Information Technology

Provectus Signs Memorandum of Understanding with Sinopharm-China...

Provectus Biopharmaceuticals, Inc. , a development-stage oncology and dermatology biopharmaceutical company , announced today that it entered into a Memorandum of Understanding with Sinopharm-China State Institute of Pharmaceutical Industry , the leader among all pharmaceutical research institutes in China, and Sinopharm A-THINK Pharmaceutical ... (more)

Comment?

Related Topix: World News, China, Asia, Oncology,

Business Journal

Bristol-Myers Squibb targets major block of space in East Cambridge

Bristol-Myers Squibb is vetting several property options in East Cambridge, increasingly the office and lab market of choice for many of the largest life sciences companies in the world.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Bristol-Myers Squibb, Waltham, MA

AmericanBankingNews.com

Achillion Pharmaceuticals Price Target Increased to $17.00 by Analysts at Deutsche Bank

The firm currently has a "buy" rating on the stock. Deutsche Bank's price target suggests a potential upside of 83.78% from the company's current price.

Comment?

Related Topix: Achillion Pharmaceuticals

•••
•••
•••
•••

Pharmaceuticals Jobs

•••
•••
•••
•••